-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – C-106 in Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - C-106 in Pulmonary Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.C-106 in Pulmonary Hypertension Drug Details:C-106 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – C-106 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - C-106 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.C-106 in Idiopathic Pulmonary Fibrosis Drug Details:C-106 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – D-4517 in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - D-4517 in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. D-4517 in Diabetic Macular Edema Drug Details: D-4517 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VP-01 in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VP-01 in Pulmonary Arterial Hypertension report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buloxibutid in Endothelial Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buloxibutid in Endothelial Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Buloxibutid in Endothelial DysfunctionDrug Details:Buloxibutid (VP-01) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buloxibutid in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buloxibutid in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Buloxibutid in Pulmonary Arterial HypertensionDrug Details:Buloxibutid (VP-01) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KRLS-004 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KRLS-004 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.KRLS-004 in Colorectal CancerDrug Details:KRLS-004 (ASN-004) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fostamatinib Disodium in Kidney Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fostamatinib Disodium in Kidney Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Fostamatinib Disodium in Kidney Transplant Rejection Drug Details:Fostamatinib disodium (Tavalisse, Tavlesse)...
-
Product Insights
Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Pulmonary Fibrosis Clinical Trials Overview The Pulmonary Fibrosis clinical trial report consists of 859 trials. The report provides an overview of the Pulmonary Fibrosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Pulmonary Fibrosis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and...
-
Company Profile
Vicor Corp – Company Profile
Vicor Corp (Vicor) designs and manufactures modular components and power systems. The company supports customers in efficiently converting and managing power from the wall plug to the point-of-load. Its customized power systems can provide specific solutions to the customer from modular, plug-and-play components to semiconductor-centric solutions. Vicor’s products find applications in enterprise and high-performance computing, telecommunications and network infrastructure, aerospace and defense electronics, industrial equipment and automation and vehicles and transportation markets. The company has an operational presence across the...
Add to Basket